Agenda
7:30 – 8:15 am | Registration Check-in & Networking Breakfast |
---|---|
8:15 – 8:30 am | Welcome & Chairman’s 2015 Year in Review |
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures | |
8:30 – 9:10 am | Drug Delivery Company Showcase |
Co-Moderated By: Dr. Rafiq Hasan, VP & Global Head, Ophthalmology – Bayer Health Care Thomas F. Zioncheck, PhD, Senior Director, Business Development – Genentech 8:30-8:38 – Ocular Therapeutix – Amar Sawhney, PhD, Chairman, President & CEO |
|
9:10 – 10:14 am | Device & Diagnostics Company Showcase |
Co-Moderated By: Andrew Chang, General Manger & VP, US Surgical – Valeant/Bausch+Lomb Patrick T. Johnson, PhD, VP, Business Development – Allergan 9:10-9:18 – Transcend Medical – Sean Ianchulev, MD, MPH, CMO & VP, Medical Affairs & Business Development |
|
10:14 – 10:45 am | Morning Refreshment & Networking Break |
10:45 am – 12:29 pm | BioPharma Company Showcase |
Co-Moderated By: Kate Benedict, CPA, VP, US Pharmaceutical Sales – Alcon Dirk Sauer, PhD, Global Head, Retina Development Franchise – Novartis Pharma AG 10:45-10:53 – Allegro Ophthalmics, LLC – Vicken Karageozian, MD, CTO & Co-Founder |
|
12:29 – 12:35 pm | Digital Ophthalmology Sector Overview |
Michelle Snyder, Chief Marketing Officer – Welltok | |
12:35 – 1:00 pm | Digital Ophthalmology Showcase |
Moderated By: Gilbert H. Kliman, MD, Managing Director – InterWest Partners 12:35-12:40 – Gobiquity – Andrew Burns, CEO |
|
1:00 pm | Lunch Commences |
1:30 – 1:55 pm | OIS Innovation Award Presentation |
1:55 – 2:15 pm | Plenary Keynote |
Brent Saunders, President & CEO – Allergan | |
2:15 pm | Lunch Concludes |
2:15 – 2:22 pm | Ophthalmic Innovation 2015 – “A View from the AAO” |
David W. Parke, II, MD, CEO – American Academy of Ophthalmology (AAO) | |
2:22 – 2:30 pm | Ophthalmic Innovation 2015 – “A View from the NEI” |
Paul A. Sieving, MD, PhD, Director, National Eye Institute (NEI) – National Institutes of Health (NIH) | |
2:30 – 2:50 pm | Alcon – Google Innovation: Visions of Ophthalmology in 2020 |
Moderated By: William J. Link, PhD, Managing Director – Versant Ventures Panel Participants: |
|
2:50 – 3:20 pm | Protecting & Monetizing IP – A Primer for Early Stage Entrepreneurs |
Moderated By: Casey McGlynn, Partner – Wilson, Sonsini, Goodrich & Rosati Panel Participants: |
|
3:20 – 3:40 pm | Afternoon Refreshment & Networking Break |
3:40 – 3:50 pm | Private Funding Trends Presentation |
Jonathan Norris, Managing Director – SVB | |
3:50 – 4:00 pm | A View of the Public Ophthalmology Market & Exit Trends |
Joseph Gilliam, Managing Director, Healthcare Investment Banking – J.P. Morgan | |
4:00 – 4:50 pm | Public Device & BioPharma Ophthalmology Company Showcase |
Moderated By: Scott Beardsley, Partner – Novo Ventures US 4:00-4:10 – Aerie Pharmaceuticals – Vince Anido, Jr., PhD, CEO & Chairman |
|
4:50 – 5:20 pm | Thinking About Market Cycles & Growth in the Ophthalmology Sector |
Moderated By: Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Venture Panel Participants: |
|
5:20 – 6:00 pm | Master of the Universe |
Moderated By: James V. Mazzo, Chairman & CEO – AcuFocus, Executive Chairman – Neurotech Panel Participants: |
|
6:00 – 6:05 pm | Wrap Up & Closing Comments |
Gilbert H. Kliman, MD, Managing Director – InterWest Partners | |
6:05 – 7:00 pm | Networking Reception |